Oxysterols in tumor immune microenvironment (TIME)

Yuanxin Liu1, Jie Qin1, Xiaorui Li2

  • 1Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

Insights

Oxysterols, cholesterol oxidation products, modulate the tumor immune microenvironment by interacting with key receptors. This interaction influences immune cell behavior, offering potential for novel cancer immunotherapy strategies.

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Oxysterols are derived from cholesterol oxidation and impact cellular processes.
  • They interact with receptors like EBI2, LXR, and PXR, influencing signaling pathways.
  • These interactions are critical in the tumor immune microenvironment (TME).

Purpose of the Study:

  • To investigate the role of oxysterols in the tumor immune microenvironment.
  • To explore how oxysterols affect immune cell function and tumor development.
  • To identify oxysterols as potential therapeutic targets in cancer immunotherapy.

Main Methods:

  • Analysis of oxysterol interactions with cell membrane and nuclear receptors (EBI2, LXR, PXR).
  • Assessment of immune cell signaling pathways (proliferation, apoptosis, migration, invasion).
  • Evaluation of oxysterol effects on immune cell populations (macrophages, T cells, dendritic cells) within the TME.

Main Results:

  • Oxysterol-receptor interactions regulate immune cell signaling pathways.
  • Altered immune cell function (macrophages, T cells, dendritic cells) within the TME.
  • Specific oxysterols enhance T cell infiltration and activation, synergizing with anti-PD-1 therapy.

Conclusions:

  • Oxysterols significantly influence the tumor immune microenvironment.
  • Understanding oxysterol mechanisms can reveal new therapeutic targets for cancer.
  • Oxysterols present innovative strategies for enhancing tumor immunotherapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K